Capital Markets
Company Overview of Morningside Ventures
Executive Profile
Stephanie Monaghan O’Brien Esq. |
| Age | Total Calculated Compensation | This person is connected to 5 Board Members in 5 different organizations across 6 different industries. See Board Relationships |
| -- | -- |
Background
Ms. Stephanie Monaghan O’Brien, Esq. serves as an Executive officer of Morningside Technologies. Ms. O’Brien worked in international portfolio analysis at Chase Manhattan Bank, N.A. She spent nine years as a Corporate Lawyer with Hale and Dorr in both the Boston and Washington. She serves as Director of Alacer Biomedical Inc., I-Behavior Inc., BiddingForGood Inc., Aduro BioTech Inc., Inimex Pharmaceuticals Inc., Aduro BioTech Inc. and Serica Technology Inc. Ms. O’Brien ...
Corporate Headquarters22nd FloorCauseway Bay, -- -- Hong Kong Phone: 852 2894 9800 Fax: 852 2577 3509 Board Members MembershipsDirector Former Director Director Director Director Director
EducationBA 1980 Harvard College JD 1985 New York University School Of Law
Other Affiliations |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- New York, NY | CapgeminiPosted: May 17
- Boston, MA |Posted: May 18
- New York, NY | Network Esc (a Division of Network Temps, Inc.)Posted: May 17
- San Francisco, CA | Robert Half Management ResourcesPosted: May 16
Sponsored Financial Commentaries
Sponsored Links
To contact Morningside Ventures, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








